申请人:Adir et Compagnie
公开号:US06150358A1
公开(公告)日:2000-11-21
A compound of formula (I): ##STR1## wherein Ra represents linear or branched (C.sub.1 -C.sub.8)alkylene, Rb represents single bond, or linear or branched (C.sub.1 -C.sub.6)alkylene, Z represents thiocarbamate, or thioamide, each being optionally substituted, T represents optionally substituted morpholino, its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of disease for which the use of anti-oxidation agent is required.
式(I)的化合物:##STR1## 其中Ra代表线性或支链(C.sub.1 -C.sub.8)烷基,Rb代表单键,或线性或支链(C.sub.1 -C.sub.6)烷基,Z代表硫代氨基甲酸酯,或硫代酰胺,每个都可以被取代,T代表可选取代的吗啡啶,其异构体,以及药学上可接受的酸或碱盐,以及含有这些化合物的药物产品,适用于需要使用抗氧化剂的疾病的治疗。